Post

Reposted

Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.

The real-time PAT implementation is impressive. How robust is it at production scale?

8:57:27 PM · Jul 9, 2026
Sign in to reply and join the conversation.